Testosterone is reported to have an acute vasodilating action in vitro, an effect that may impart a favourable haemodynamic response in patients with chronic heart failure. However, the effect of chronic testosterone exposure on general vascular reactivity is poorly described. In the present study, fresh subcutaneous resistance arteries were obtained from patients with heart failure (n=10), healthy controls (n=9) and men with androgen-deficiency (n=17). All arteries were studied using a wire myograph to examine the effect of cumulative additions of testosterone (1 nmol/l–100 μmol/l) compared with vehicle control following maximal pre-constriction with KCl (1–100 μmol/l). The vascular reactivity of arteries from androgen-deficient patients was examined further by recording tension concentration curves to cumulative additions of noradrenaline (1 nmol/l–100 μmol/l) and U46619 (1–300 nmol/l), followed by relaxation concentration curves to additions of ACh (acetylcholine; 10 nmol/l–30 μmol/l) and SNP (sodium nitroprusside; 10 nmol–30 μmol/l) respectively. In all cases, statistical analysis was performed by ANOVA. Patients with proven androgen-deficiency were treated according to clinical recommendations for a minimum of 3 months and further arteries (n=19) were taken for experimentation using the same protocol. In all groups, testosterone was confirmed to be an acute concentration-dependent vasodilator at concentrations ≥1 μmol/l (P=0.0001). The dilating effect of testosterone was augmented in patients with androgen-deficiency prior to treatment, and this effect was abrogated following appropriate testosterone replacement. Testosterone therapy significantly reduced the normal vascular dilating response to ACh and SNP (P<0.01) and significantly increased the contractile response to noradrenaline (P<0.01), but not U46619. Testosterone is an acute dose-dependent vasodilator of resistance arteries. Physiological testosterone replacement attenuates general vascular reactivity in androgen-deficient subjects. The numerous perceived benefits of testosterone replacement may be offset by a decline in vascular reactivity and, therefore, further studies and careful monitoring of patients is recommended.
Skip Nav Destination
Article navigation
October 2006
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Research Article|
September 13 2006
Effect of testosterone on ex vivo vascular reactivity in man
Christopher J. Malkin;
Christopher J. Malkin
*Department of Cardiology Research, Royal Hallamshire Hospital Sheffield, Sheffield S10 2JF, U.K.
Search for other works by this author on:
Richard D. Jones;
Richard D. Jones
†Academic Unit of Endocrinology, Division of Genomic Medicine, University of Sheffield, Sheffield S10 2JF, U.K.
Search for other works by this author on:
T. Hugh Jones;
T. Hugh Jones
†Academic Unit of Endocrinology, Division of Genomic Medicine, University of Sheffield, Sheffield S10 2JF, U.K.
Search for other works by this author on:
Kevin S. Channer
*Department of Cardiology Research, Royal Hallamshire Hospital Sheffield, Sheffield S10 2JF, U.K.
Correspondence: Professor Kevin S. Channer (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
November 29 2005
Revision Received:
February 20 2006
Accepted:
May 25 2006
Accepted Manuscript online:
May 25 2006
Online ISSN: 1470-8736
Print ISSN: 0143-5221
The Biochemical Society
2006
Clin Sci (Lond) (2006) 111 (4): 265–274.
Article history
Received:
November 29 2005
Revision Received:
February 20 2006
Accepted:
May 25 2006
Accepted Manuscript online:
May 25 2006
Connected Content
This is a commentary on:
Testosterone and vascular reactivity
Citation
Christopher J. Malkin, Richard D. Jones, T. Hugh Jones, Kevin S. Channer; Effect of testosterone on ex vivo vascular reactivity in man. Clin Sci (Lond) 1 October 2006; 111 (4): 265–274. doi: https://doi.org/10.1042/CS20050354
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |